2023 AADOCR/CADR Annual Meeting & Exhibition

Attendees must be fully vaccinated by the date of their first day of attending the Annual Meeting or associated Annual Meeting venues. Full vaccination status is defined as having finished your vaccine, whether that's one dose or two. All WHO approved vaccinations will be accepted. AADOCR reminds you it can take up to six weeks to complete the full schedule for COVID-19 vaccines that require two doses. Please plan accordingly.

Please note that proof of vaccination will be required for all in-person meeting attendees prior to picking up their registration badge in Portland.

The vaccines that are required are:
A 2-dose series of an mRNA COVID-19 vaccine (Pfizer-BioNTech, Moderna or Novavax), or
A single-dose COVID-19 vaccine Johnson & Johnson's Janssen vaccine).

Boosters

The Pfizer-BioNTech, Moderna (COVID-19 mR NA) and Novavax vaccines are preferred. As of January 5, 2022, the CDC is now recommending you stay up-to -date with your vaccines. This includes additional doses.

For individuals who are immunocompromised or booster doses. 

Attendees should be aware that, while AADOCR will make every effort to reduce the risk of COVID-19 transmission on site, it is possible that attendees will come in contact with people In airports, hotels, and around the convention center who could potentially carry the virus, which is why AADOCR is requiring attendees to be fully vaccinated for their own safety, as well as the safety of others.

All AADOCR staff working at the meeting will be fully vaccinated; however, AADOCR is not legally able to require local convention center or hotel staff to be vaccinated. AADOCR is working with local entities in Portland to develop on­ site protocols in accordance with CDC guidelines, including requiring all local convention center staff to wear masks during the AADOCR meeting.

Prior to arriving to the AADOCR registration area, attendees will be asked to provide proof that they are fully vaccinated with a vaccine approved by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO) by showing a vaccine card or photo of vaccine verification at Security Checkpoints.

Please be sure to travel with a copy of your vaccine verification card or a photo of the vaccine verification with your name.

AADOCR/CADR reserves the right to require documentation or verification of vaccination as part of the registration process and participation in the Annual Meeting & Exhibition. The AADOCR and CADR are partnering with a third-party company to verify vaccination status and to ensure that privacy protocols are implemented throughout the verification process. Details on providing vaccine verification will be available on our website in the coming weeks.

Regardless of vaccination status, attendees should conduct a self-check for the following symptoms prior to attending the Annual Meeting. Within the past 48 hours has the individual experienced:

• fever or chills
• cough
• shortness of breath or difficulty breathing
• fatigue
• muscle or body aches
• headache
• new loss of taste or smell
• sore throat
• congestion or runny nose
• nausea or vomiting
• diarrhea  

As part of our commitment to the safety at the 2023 AADOCR/CADR Annual Meeting & Exhibition, all attendees must provide proof of vaccination before receiving their conference badge at registration. 

Attendees participating in-person are strongly encouraged to test themselves immediately before traveling to Portland. Testing at home before travel, either a rapid antigen test or more ideally a PCR, will add a further layer of protection for all attendees. Obviously, attendees who test positive should stay home, follow other CDC and local guidelines, and will still be able to view sessions on demand post-meeting. In addition, pre-travel testing will detect early asymptomatic infections and avoid the potential for transmission to fellow attendees and the more costly and inconvenient possibility of a quarantine in Portland. 

International attendees should always check current travel restrictions to the U.S. on the Centers for Disease Control and Prevention (CDC) website before planning your travel, to make sure you will be able to enter the U.S.

Because even fully vaccinated individuals can potentially become infected and transmit SARS -CoV-2, especially the latest variant, high-quality (N95 or similar masks) will be required to be worn by attendees. Surgical or cloth masks are not sufficient to prevent the transmission of  the airborne virus.  Attendees are expected to bring their own supply of N95 masks. Upon request, one N95 mask will be provided to in-person delegates at the registration desk.

Meeting rooms will be set up to accommodate more personal space for social distancing. The Oregon Convention Center has been certified with the GBAC STAR which aligns infection prevention, cleaning & disinfection programs with science.

MERV-13 air filtration has been provided in all meeting rooms and public spaces. On-site convention center staff will clean high-touch surfaces, lecterns, and internet stations regularly to promote healthy sanitation overall and hand sanitizers are located throughout the building.

PCR and rapid antigen COVID-19 testing is available by appointment Monday to Friday from 8am – 5pm in downtown Portland. 

(NOTE: The reason for this is that the current test site at the convention center is contracted through Dec. and they are not certain it will be renewed for 2023).

To schedule an appointment, visit curative.com. Walk-ups may be accepted. Call 888-702-9042 to confirm. Learn more.

Information on health and safety procedures for events hosted in Oregon Convention Center in Portland, Oregon. https://www.oregoncc.org/en/venue-2020-coronavirus-covid-19-faq

• Timely updates and information on health and safety procedures when traveling to and while in Portland OR.

AADOCR encourages attendees to visit their hotel's website or  connecting with a hotel representative for the most up­ to -date health and safety information for individual hotels.